Circulating levels of asymmetric dimethylarginine are an independent risk factor for left ventricular hypertrophy and predict cardiovascular events in pre-dialysis patients with chronic kidney disease

European Journal of Internal Medicine

Volumn 21, Issue 5, 2010, Pages 444-448

  Shi, Beili ^a   Ni, Zhaohui ^a   Zhou, Wenyan ^a   Yu, Zanzhe ^a   Gu, Leyi ^a   Mou, Shan ^a   Fang, Wei ^a   Wang, Qin ^a   Cao, Liou ^a   Yan, Yucheng ^a   Qian, Jiaqi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Asymmetric dimethylarginine; Cardiovascular disease; Chronic kidney disease; Left ventricular hypertrophy

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ADULT; ARTICLE; BLOOD CHEMISTRY; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE HYPERTROPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; ARGININE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 77956407839     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.07.001     Document Type: Article

References (23)

1. R.N. Foley, P.S. Parfrey, and M.J. Sarnak Epidemiology of cardiovascular disease in chronic renal disease J Am Soc Nephrol 9 Suppl 12 1998 S16 S23
2. R.M. Henry, P.J. Kostense, G. Bos, J.M. Dekker, G. Nijpels, and R.J. Heine Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study Kidney Int 62 4 2002 1402 1407
3. P. Muntner, J. He, L. Hamm, C. Loria, and P.K. Whelton Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 3 2002 745 753
4. L. Zhang, L. Zuo, F. Wang, M. Wang, S. Wang, and J. Lv Cardiovascular disease in early stages of chronic kidney disease in a Chinese population J Am Soc Nephrol 17 9 2006 2617 2621
5. C. Zoccali, F.A. Benedetto, R. Maas, F. Mallamaci, G. Tripepi, and L.S. Malatino Asymmetric dimethylarginine, c-reactive protein, and carotid intima-media thickness in end-stage renal disease J Am Soc Nephrol 13 2 2002 490 496
6. C. Zoccali, F. Mallamaci, R. Maas, F.A. Benedetto, G. Tripepi, and L.S. Malatino Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients Kidney Int 62 1 2002 339 345
7. C. Zoccali, S. Bode-Böger, F. Mallamaci, F. Benedetto, G. Tripepi, and L. Malatino Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end stage renal disease: a prospective study Lancet 358 9299 2001 2113 2117
8. J.M. Young, N. Terrin, X. Wang, T. Greene, G.J. Beck, and J.W. Kusek Asymmetric dimethylarginine and mortality in stages 3 to 4 chronic kidney disease Clin J Am Soc Nephrol 4 2009 1115 1120
9. L. Raij Nitric oxide in hypertension: relationship with renal injury and left ventricular hypertrophy Hypertens 31 1998 189 193
10. T. Sládek, M. Gerová, V. Znojil, and L. Devát Morphometric characteristics of cardiac hypertrophy induced by long-term inhibition of NO synthase Physiol Res 45 1996 335 338
11. M.J. Sarnak, A.S. Levey, A.C. Schoolwerth, J. Coresh, B. Culleton, and L.L. Hamm Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention Hypertens 42 5 2003 1050 1065
12. Jens Martens-Lobenhoffer, and Stefanie M. Bode-Böger Simultaneous detection of arginine, asymmetric dimethylarginine, symmetric dimethylarginine and citrulline in human plasma and urine applying liquid chromatography-mass spectrometry with very straightforward sample preparation J Chromatogr B 798 2 2003 231 239
13. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification: guideline 4: estimation of GFR Am J Kid Dis 39 Suppl 1 2002 S83 S86
14. D. Fliser, F. Kronenberg, J.T. Kielstein, C. Morath, S.M. Bode-Böger, and H. Haller Asymmetric dimethylarginine and progression of chronic kidney disease: the mild to moderate kidney disease study J Am Soc Nephrol 16 8 2005 2456 2461
15. R. Wever, P. Boer, M. Hijmering, E. Stroes, M. Verhaar, and J. Kastelein Nitric oxide production is reduced in patients with chronic renal failure Arterioscler Thromb Vasc Biol 19 1999 1168 1172
16. R.J. Schmidt, and C. Baylis Total nitric oxide production is low in patients with chronic renal disease Kidney Int 58 2000 1261 1266
17. C. van Guldener, J. Lambert, M.J. Janssen, A.J. Donker, and C.D. Stehouwer Endothelium dependent vasodilatation and distensibility of large arteries in chronic haemodialysis patients Nephrol Dial Transplant 12 Suppl 2 1997 14 18
18. S. Xiao, L. Wagner, R.J. Schmidt, and C. Baylis Circulating endothelial nitric oxide synthase inhibitory factor in some patients with chronic renal disease Kidney Int 59 2001 1466 1472
19. H.O. El-Mesallamy, S.G. Abdel Hamid, and M.Z. Gad Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by l-arginine intake. Kidney Blood Press Res 31 3 2008 189 195
20. M. Lajer, L. Tarnow, A. Jorsal, T. Teerlink, H.H. Parving, and P. Rossing Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy Diab Care 31 4 2008 747 752
21. F. Perticone, R. Maio, R. Ceravolo, C. Cosco, C. Cloro, and P.L. Mattioli Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients Circulation 99 1999 1991 1996
22. P.J. Kuhlencordt, R. Gyurko, F. Han, M. Scherrer-Crosbie, T.H. Aretz, and R. Hajjar Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knock-out mice Circulation 104 2001 448 454
23. M. Busch, C. Fleck, G. Wolf, and G. Stein Asymmetrical (ADMA) and symmetrical dimethylarginine (SDMA) as potential risk factors for cardiovascular and renal outcome in chronic kidney disease - possible candidates for paradoxical epidemiology? Amino Acids 30 3 2006 225 232